标题
Ovarian cancer treatment: The end of empiricism?
作者
关键词
-
出版物
CANCER
Volume 121, Issue 18, Pages 3203-3211
出版商
Wiley
发表日期
2015-06-19
DOI
10.1002/cncr.29481
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 878PDBENEFICIAL EFFECT OF ADJUVANT CHEMOTHERAPY AND WHOLE ABDOMINAL OR PELVIC RADIOTHERAPY (WAPRT) ON PROGRESSION FREE AND OVERALL SURVIVAL FOLLOWING PRIMARY SURGERY IN PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA (OCCC)
- (2017) D.S. Tan et al. ANNALS OF ONCOLOGY
- Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
- (2015) M. P. Morelli et al. ANNALS OF ONCOLOGY
- Evaluation of Gynecologic Cancer with MR Imaging, 18F-FDG PET/CT, and PET/MR Imaging
- (2015) S. I. Lee et al. JOURNAL OF NUCLEAR MEDICINE
- Outcomes and endpoints in trials of cancer treatment: the past, present, and future
- (2015) Michelle K Wilson et al. LANCET ONCOLOGY
- Outcomes and endpoints in cancer trials: bridging the divide
- (2015) Michelle K Wilson et al. LANCET ONCOLOGY
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Immunotherapy for ovarian cancer
- (2014) Emese Zsiros et al. CURRENT OPINION IN ONCOLOGY
- Global distribution pattern of histological subtypes of epithelial ovarian cancer: A database analysis and systematic review
- (2014) Pi-Lin Sung et al. GYNECOLOGIC ONCOLOGY
- Patterns of Recurrence and Role of Pelvic Radiotherapy in Ovarian Clear Cell Adenocarcinoma
- (2014) Bryan D. Macrie et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Epithelial Ovarian Cancer
- (2014) Evelyn Despierre et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian and Primary Peritoneal Low-Grade Serous Carcinomas
- (2014) Charlie Gourley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Better Therapeutic Trials in Ovarian Cancer
- (2014) M. A. Bookman et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
- (2014) Ronald Lebofsky et al. Molecular Oncology
- Tissue specificity in DNA repair: lessons from trinucleotide repeat instability
- (2014) Vincent Dion TRENDS IN GENETICS
- Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells
- (2014) Federica Tomao et al. Journal of Cancer
- Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
- (2014) Evan J Lipson et al. Journal for ImmunoTherapy of Cancer
- Clinical implications of using molecular diagnostics for ovarian cancers
- (2013) E. C. Kohn et al. ANNALS OF ONCOLOGY
- Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunities
- (2013) Angela Esposito et al. CANCER TREATMENT REVIEWS
- Early Telomere Shortening and Genomic Instability in Tubo-Ovarian Preneoplastic Lesions
- (2013) G. Chene et al. CLINICAL CANCER RESEARCH
- Genomic and transcriptomic plasticity in treatment-naive ovarian cancer
- (2013) M. Hoogstraat et al. GENOME RESEARCH
- Clinical Trials of Palliative Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: Time to Think Differently?
- (2013) Michael L. Friedlander et al. JOURNAL OF CLINICAL ONCOLOGY
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study
- (2013) Ignace B. Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Should studies of maintenance therapy be maintained in women with ovarian cancer?
- (2013) Michael A. Bookman Journal of Gynecologic Oncology
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
- (2012) Michael S. Glickman et al. CELL
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Hormone response in ovarian cancer: time to reconsider as a clinical target?
- (2012) Francesmary Modugno et al. ENDOCRINE-RELATED CANCER
- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
- (2012) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation
- (2012) Paul J. Hoskins et al. JOURNAL OF CLINICAL ONCOLOGY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- BRCAness: Finding the Achilles Heel in Ovarian Cancer
- (2012) G. Rigakos et al. ONCOLOGIST
- A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer
- (2011) Angeles Alvarez Secord et al. CANCER
- Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature review
- (2011) Y. Pan et al. Current Oncology
- Clinical Trials in Recurrent Ovarian Cancer
- (2011) Michael Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Early versus delayed treatment of relapsed ovarian cancer
- (2011) Gordon Rustin et al. LANCET
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer
- (2010) Lisa M. Hess et al. CANCER
- Weekly Low-Dose Paclitaxel as Maintenance Treatment in Patients With Advanced Ovarian Cancer Who Had Microscopic Residual Disease at Second-Look Surgery After 6 Cycles of Paclitaxel/Platinum-Based Chemotherapy
- (2010) Angiolo Gadducci et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance Chemotherapy: An Evolving and Increasingly Acceptable Strategy in Cancer Management
- (2010) Maurie Markman Current Oncology Reports
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
- (2009) Maurie Markman et al. GYNECOLOGIC ONCOLOGY
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Maintenance Therapy for Ovarian Cancer: Of Helsinki and Hippocrates
- (2009) William Patrick McGuire JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1
- (2009) Sergio Pecorelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy
- (2008) Nilofer S. Azad et al. CANCER
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started